πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 109 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12377112

Methods of treating neurocognitive disorders, chronic pain and reducing inflammation

Compass Pathfinder Limited Β· Granted Tue Aug 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12312375

Preparation of psilocybin, different polymorphic forms, intermediates, formulations and th

Compass Pathfinder Limited Β· Granted Tue May 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12286483

Method of treating cancer using CD137 antibodies and PD-1 antagonists

Compass Therapeutics LLC Β· Granted Tue Apr 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12186285

Compositions and methods of treatment for tinea pedis

Compass Therapeutics LLC Β· Granted Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12070594

Biomedical electrode with anti-microbial properties

COMPASS HEALTH BRANDS CORP. Β· Granted Tue Aug 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11970538

Multispecific binding constructs against checkpoint molecules and uses thereof

Compass Therapeutics LLC Β· Granted Tue Apr 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11939346

Preparation of psilocybin, different polymorphic forms, intermediates, formulations and th

Compass Pathfinder Limited Β· Granted Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11865126

Method for treating anxiety disorders, headache disorders, and eating disorders with psilo

Compass Pathfinder Limited Β· Granted Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11865179

Progesterone formulations having a desirable PK profile

Compass Therapeutics LLC Β· Granted Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11851451

Preparation of psilocybin, different polymorphic forms, intermediates, formulations and th

Compass Pathfinder Limited Β· Granted Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11851497

CD137 antibodies and tumor antigen-targeting antibodies and uses thereof

Compass Therapeutics LLC Β· Granted Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11793819

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC Β· Granted Tue Oct 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11766558

Biomedical electrode with anti-microbial properties

COMPASS HEALTH BRANDS CORP. Β· Granted Tue Sep 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11752207

Agonist antibodies that bind human CD137 and uses thereof

Compass Therapeutics LLC Β· Granted Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11738035

Method for treating anxiety disorders, headache disorders, and eating disorders with psilo

Compass Pathfinder Limited Β· Granted Tue Aug 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11718679

CD137 antibodies and PD-1 antagonists and uses thereof

Compass Therapeutics LLC Β· Granted Tue Aug 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11661617

Processes for the production of tryptamines

Compass Pathfinder Limited Β· Granted Tue May 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11633405

Steroid hormone pharmaceutical formulations

Compass Therapeutics LLC Β· Granted Tue Apr 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11629159

Preparation of psilocybin, different polymorphic forms, intermediates, formulations and th

Compass Pathfinder Limited Β· Granted Tue Apr 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11622933

Soluble estradiol capsule for vaginal insertion

Compass Therapeutics LLC Β· Granted Tue Apr 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11564935

Method for treating anxiety disorders, headache disorders, and eating disorders with psilo

Compass Pathfinder Limited Β· Granted Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11529360

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC Β· Granted Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11505564

Preparation of psilocybin, different polymorphic forms, intermediates, formulations and th

Compass Pathfinder Limited Β· Granted Tue Nov 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11497709

Vaginal inserted estradiol pharmaceutical compositions and methods

Compass Therapeutics LLC Β· Granted Tue Nov 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted